Artículos por temáticas

Cardiovascular risk and mortality in end-stage renal disease patients with restless legs syndrome; need for further investigation and looking for underlying mechanisms.

Gholamrezaei A, Amra B, Mortazavi M.

Sleep Med. 2013 Apr;14(4):385-6. doi: 10.1016/j.sleep.2012.11.015. No abstract available.

Does Restless Legs Syndrome increase cardiovascular risk in Attention-Deficit/Hyperactivity Disorder?

Angriman M, Bruni O, Cortese S.

Med Hypotheses. 2013 Jan;80(1):39-42. doi: 10.1016/j.mehy.2012.10.004.

Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study.

Giannaki CD, Sakkas GK, Karatzaferi C, Hadjigeorgiou GM, Lavdas E, Kyriakides T, Koutedakis Y, Stefanidis I.

BMC Nephrol. 2013 Sep 11;14:194. doi: 10.1186/1471-2369-14-194.

Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 - 3 mg/24 h for up to 5 years.

Dohin E, Högl B, Ferini-Strambi L, Schollmayer E, Fichtner A, Bauer L, García-Borreguero D.

Expert Opin Pharmacother. 2013 Jan;14(1):15-25. doi: 10.1517/14656566.2013.758251.

Treatment for Restless Legs Syndrome: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 86 [Internet].

Carlyle M, Ouellette J, Khawaja I, Wilt TJ.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Feb.

The influence of parathyroidectomy on restless legs syndrome in patients with renal hyperparathyroidism.

Schneider R, Karakas E, Bartsch DK, Schlosser K.

World J Surg. 2013 Dec;37(12):2866-71.

Pramipexole induced psychosis in a patient with restless legs syndrome.

Signorelli MS, Battaglia E, Costanzo MC, Cannavò D.

BMJ Case Rep. 2013 Sep 18;2013. pii: bcr2013009716. doi: 10.1136/bcr-2013-009716.

'Restless bladder' and the boundaries of the restless legs syndrome.

Antelmi E, Coccagna G, Ferini-Strambi L, Marelli S, Provini F.

Eur J Neurol. 2013 Nov;20(11):e128. doi: 10.1111/ene.12242. No abstract available.

Restless legs syndrome -- secondary, comorbid or coincidental?

Sieminski M.

Eur Neurol. 2013;69(3):150-1. doi: 10.1159/000345372. No abstract available.

A single-blind randomized controlled trial to evaluate the effect of 6 months of progressive aerobic exercise training in patients with uraemic restless legs syndrome.

Giannaki CD, Hadjigeorgiou GM, Karatzaferi C, Maridaki MD, Koutedakis Y, Founta P, Tsianas N, Stefanidis I, Sakkas GK.

Nephrol Dial Transplant. 2013 Nov;28(11):2834-40. doi: 10.1093/ndt/gft288.

Opioids and restless legs syndrome.

Walters AS.

Lancet Neurol. 2013 Dec;12(12):1128-9. doi: 10.1016/S1474-4422(13)70248-5. No abstract available.

Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose.

Grim K, Lee B, Sung AY, Kotagal S.

Sleep Med. 2013 Nov;14(11):1100-4. doi: 10.1016/j.sleep.2013.06.006.

Clozapine-induced restless legs syndrome treated with aripiprazole.

Raveendranathan D, Shiva L, Venkatasubramanian G, Rao MG, Varambally S, Gangadhar BN.

J Neuropsychiatry Clin Neurosci. 2013 Spring;25(2):E62-3. doi: 10.1176/appi.neuropsych.12050128. No abstract available.

Association of restless legs syndrome variants in Korean patients with restless legs syndrome.

Kim MK, Cho YW, Shin WC, Cho JW, Shon YM, Kim JH, Yang KI, Earley CJ, Allen RP.

Sleep. 2013 Dec 1;36(12):1787-91. doi: 10.5665/sleep.3200.

Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2.

Lam EM, Shepard PW, St Louis EK, Dueffert LG, Slocumb N, McCarter SJ, Silber MH, Boeve BF, Olson EJ, Somers VK, Milone M.

Neurology. 2013 Jul 9;81(2):157-64. doi: 10.1212/WNL.0b013e31829a340f.